CEO
at Ubuntu Research
Vishal Mehta founded Ubuntu Research Inc. to accelerate the delivery of innovative therapies in a sustainable and modern way. With over 20 years of experience spanning pharma, biotech, and CRO sectors, he brings deep expertise in drug development strategy, clinical execution, and agile operations. Vishal has contributed to numerous impactful therapies, including CAR T treatments BREYANZI® and ABECMA®, targeted therapies KISQALI® and AFINITOR®, the immunotherapy YERVOY®, biosimilars, and various life cycle management programs in oncology and beyond. He holds a B.S. in Pharmaceutical Sciences from the University of Mumbai and an M.S. in Clinical Research & Administration from George Washington University.
Education
The George Washington University School of Medicine and Health Sciences
K.M. Kundnani College of Pharmacy
Awards & Certifications
LinkedIn logo Succeeding in a New Role By Managing Up Succeeding in a New Role By Managing Up LinkedIn
Areas of Expertise
Got a Question for Vishal Mehta?
Get in touch using the contact form linked here and we'll get back to you shortly.
